Analysis for UNH
- 📈 Growth — 20/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 17/20
- 💵 Valuation — 15/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
Over the eight quarters, revenues rise from about $100.8B in 2024 Q3 to about $112.0B in 2026 Q2, an ~11% gain. Net income fluctuates: ~$6.26B in 2024 Q3, peak ~$6.47B in 2025 Q1, dip to ~$2.18B in 2025 Q4, then rebound to ~$5.67B in 2026 Q2. The path shows top-line resilience with earnings volatility, including a mid-period trough followed by a rebound in early 2026.
💰 Margins & Cash Flow
Gross margins sit in the mid-to-upper 80s%. Operating margins oscillate but stay positive; benefits costs rise, yet profitability remains solid. Net cash flow from operating activities is robust and trends higher into 2026, supporting liquidity, while investing/financing cash flows vary but do not erode operating strength.
🛡️ Balance Sheet & Liquidity
Balance sheet remains asset-rich (~$309–$312B) with Equity around $98–100B and current liabilities ~ $111–$115B. Current ratio sits near 0.8–1.0, signaling manageable liquidity. No material long-term leverage anomaly; cash generation underpins balance-sheet resilience.
⚠️ Key Drivers & Risks
- Drivers: Scale in managed care operations and cost-management effectiveness; steady premium revenue.
- Risks: Earnings volatility from benefits costs and regulatory/policy shifts; valuation sensitivity to margin fluctuations.